Physician profile

Theodore M Teacher

Neurology (Psychiatry & Neurology) · Mission Viejo, CA

NPI 1871514729

$6,531.82

in general payments reported to CMS, 2019-2025

40 companies · $1,114 in 2025

The $1,114 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

See the full distribution for Neurology (Psychiatry & Neurology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,091.35
Education$1.75

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,313.56 2021-2025 Ubrelvy, Qulipta, Botox
Biogen, INC. $500.84 2019-2025 Vumerity, Leqembi, Avonex
Lilly USA, LLC $477.54 2019-2025 Kisunla, Amyvid, Emgality
Ucb, INC. $409.90 2019-2025 Rystiggo, Briviact
Supernus Pharmaceuticals, INC. $395.46 2019-2020
Sk Life Science, INC. $326.88 2020-2025 Xcopri
Allergan, INC. $276.17 2019-2020
Acadia Pharmaceuticals INC $267.34 2019-2025 Nuplazid
Alexion Pharmaceuticals, INC. $225.41 2019-2025 Ultomiris
Novartis Pharmaceuticals Corporation $218.37 2021-2025
Amneal Pharmaceuticals LLC $192.00 2022-2025 Crexont, Rytary
Emd Serono, INC. $183.83 2021-2025
Genzyme Corporation $179.29 2019-2022
Lundbeck LLC $159.67 2023-2025 Rexulti, Vyepti
Amgen INC. $144.68 2019-2022
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Biohaven Pharmaceuticals, INC. $144.30 2021
Teva Pharmaceuticals USA, INC. $138.73 2020-2024 Austedo Xr
Neurocrine Biosciences, INC. $112.73 2022-2025 Ingrezza
Tg Therapeutics, INC. $100.05 2023-2025
Eisai INC. $96.98 2023-2025
Sunovion Pharmaceuticals INC. $94.31 2021
Abbott Laboratories $79.90 2022-2025 Infinity
Pfizer INC. $55.58 2023-2025
Celgene Corporation $41.97 2021-2023 Zeposia
Vanda Pharmaceuticals INC. $41.46 2024-2025 Ponvory
Tanabe Pharma America, INC. $34.94 2021-2024
Janssen Pharmaceuticals, INC $34.50 2022
Assertio Therapeutics, INC. $33.33 2020
Acorda Therapeutics, INC $29.51 2023 Inbrija
Akcea Therapeutics, INC. $28.99 2019
Biohaven Pharmaceutical Holding Company LTD. $27.69 2022
Otsuka America Pharmaceutical, INC. $26.00 2024 Rexulti
Genentech USA, INC. $24.73 2020
Corium, LLC $21.90 2022
Impel Pharmaceuticals INC. $19.60 2023 Trudhesa
Ge Healthcare $18.81 2023
Scilex Pharmaceuticals INC. $14.74 2024
Impel Pharmaceuticals LLC $14.40 2024 Trudhesa
Kyowa Kirin, INC. $13.34 2024 Nourianz
Adamas Pharmaceuticals, INC. $12.39 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Theodore M Teacher

$6,531.82

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $1,114 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

https://glasscript.com/doctor/39013/theodore-m-teacher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.